Venus bags Japanese patent for Elores

03 Jul 2013 Evaluate

Venus Remedies has received patent from the Japanese Patent Office for Elores, the Antibiotic against Superbugs. The company is expecting to launch this product in Japanese market by end of 2015. Elores was launched in Indian market in January this year and has received tremendous response from medical fraternity.

Elores has a unique profile of action which gives it an edge over all the existing therapies. This unique antibiotics adjuvant entity creates a synergistic effect due to its activity on Muli-drug resistant ESBL/MBL producing gram negative bacteria. lt not only kills resistant pathogens but also prevents spread of resistance.

Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.

Venus Remedies Share Price

784.80 7.30 (0.94%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×